community-acquired pneumonia: doxycycline works well
It is generally problematic finding studies comparing newer antibiotics to older antibiotics (or studies including pretty much any other types of older medications), given that studies are largely paid for by drug companies, and it could turn out that the old medications are as good as , or perhaps better than, the new ones the drug companies are trying to promote. An analysis, based on older studies, found that doxycycline seems to be as efficacious as macrolides or fluoroquinolones in treating mild - to - moderate community acquired pneumonia (see pneumonia CAP doxycycline helps CID2023 in dropbox, or doi.org/10.1093/cid/ciac615) Details : -- a systematic review/meta-analysis of 6 randomized controlled trials with 834 patients performed between 1984 and 2004 that compared doxycycline to 3 macrolides (roxithromycin, spiramycin, and erythromycin) and 3 fluoroquinolones (ofloxacillin, fleroxacin...